Uncategorized Archives - Oncology Central Oncology Central

Must read

12 Oct 2018
Vote for your winner of the Capturing Cancer: Oncology Central Photography Competition

Must watch

13 Feb 2019 Lung
Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

14 Nov 2018 Pancreatic
Emerging treatment options for pancreatic cancer with Thomas Seufferlein
14 Sep 2018 Breast
Tamoxifen, SERMs and sustainable medicine
14 Sep 2018 Immuno-oncology
Seven challenges in immuno-oncology
18 Jun 2018 Head and neck
The importance of a multidisciplinary team in the care of head and neck cancer

Stay up to date

Upcoming event

ESMO Breast Cancer 2019 – annual congress

May 2, 2019 – May 4, 2019

Berlin, Germany

View all

Upcoming event

American Society of Clinical Oncology (ASCO) annual meeting

May 31, 2019 – June 4, 2019

IL, USA

View all

Tweets

Andor Technology @AndorTechnology·

We are sponsoring an expert panel discussion on the potential of organoids on cancer research on Monday 24 June.

Register below and tune in at 7am PDT | 10am EDT | 3pm BST

https://t.co/qwQ9xXVI60 https://t.co/iAHUZ1a3RL

View all

Jobs

Connecting talent with opportunity. View our featured jobs

View all

Vote for your winner of the Capturing Cancer: Oncology Central Photography Competition

Instagram

In Focus: Breast Cancer

Speaker: Kim Buxton (Loughborough University, UK)

Speaker: Karan Thomas (Health Development Consultancy)

Speaker: Susannah Brown (World Cancer Research Fund International, UK)

Thank you for requesting our ‘Sponsorship opportunities’ pack

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Researchers identify a novel way to target chemo-resistance leukaemia cells – an interview with Peter Stern

Immune checkpoint inhibitors for hepatocellular carcinoma

Study further elucidates the mechanism of brain cancer spread

ESMO16: Pembrolizumab shows therapeutic potential in non-small-cell lung cancer

ESMO16: Phase I study of novel anticancer drug identifies responders via tumor mRNA

ASTRO16 news round-up

Selective internal radiation therapy in treatment of hepatocellular carcinoma: new concepts of personalization

Conformal radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma: is it safe?

First results from ProtecT trial in prostate cancer published

GE Healthcare: Innovation to improve breast cancer diagnostics

Role of rare germline copy number variation in melanoma-prone patients

Clinical relevance of the molecular landscape in cancers of unknown primary

Melanoma: when physician becomes patient

Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma

US FDA grant approval of pembrolizumab for advanced head & neck cancer

Low-dose brachytherapy strategies to treat uveal melanoma: is less more?

Login

Uncategorized

Must read

Vote for your winner of the Capturing Cancer: Oncology Central Photography Competition

Instagram

In Focus: Breast Cancer

Speaker: Kim Buxton (Loughborough University, UK)

Speaker: Karan Thomas (Health Development Consultancy)

Speaker: Susannah Brown (World Cancer Research Fund International, UK)

Thank you for requesting our ‘Sponsorship opportunities’ pack

Must watch

Tumor clonality and resistance mechanisms in EGFR mutation-positive NSCLC: implications for therapeutic sequencing

Emerging treatment options for pancreatic cancer with Thomas Seufferlein

Tamoxifen, SERMs and sustainable medicine

Seven challenges in immuno-oncology

The importance of a multidisciplinary team in the care of head and neck cancer

Researchers identify a novel way to target chemo-resistance leukaemia cells – an interview with Peter Stern

Immune checkpoint inhibitors for hepatocellular carcinoma

Study further elucidates the mechanism of brain cancer spread

ESMO16: Pembrolizumab shows therapeutic potential in non-small-cell lung cancer

ESMO16: Phase I study of novel anticancer drug identifies responders via tumor mRNA

ASTRO16 news round-up

Selective internal radiation therapy in treatment of hepatocellular carcinoma: new concepts of personalization

Conformal radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma: is it safe?

First results from ProtecT trial in prostate cancer published

GE Healthcare: Innovation to improve breast cancer diagnostics

Role of rare germline copy number variation in melanoma-prone patients

Clinical relevance of the molecular landscape in cancers of unknown primary

Melanoma: when physician becomes patient

Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma

US FDA grant approval of pembrolizumab for advanced head & neck cancer

Low-dose brachytherapy strategies to treat uveal melanoma: is less more?

Stay up to date

Oncology Central Newsletter